Fundraising Fox
Find your path to Harry
436 people in our graph can introduce you to Harry.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jonathan Finn to introduce you to Harry
You →Jonathan · together at Scientia Ventures (2016–2026) →Harry
Ask Jamie Chen to introduce you to Harry
You →Jamie · together at Scientia Advisors →Harry
Ask Sam Okafor to introduce you to Harry
You →Sam · together at StageZero Life Sciences →Harry
Sign up to find every way you can get introduced to Harry
- Your email: the people you already email who know Harry
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Harry
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, with over three decades of experience building, investing in, and advising companies across healthcare, life sciences, and data-driven technology. He previously served as an Entrepreneur-in-Residence at GE Ventures' New Business Creation Group, where he co-founded Evidation Health and DrawBridge Health, and earlier co-founded and led Scientia Advisors, which Precision for Medicine acquired in 2012. He is the author of four books and hosts a podcast on AI and the data-driven transformation of healthcare, and holds an MBA from Boston University and a bachelor's degree from San Francisco State University.
Contact· published on Harry's own website
Invests in
AI & Machine LearningBiotechDigital HealthHealthtech
Experience
- Scientia VenturesGeneral Partnercurrent2016 — presentUnited States
- MIT Media LabResearch Affilatecurrent2025 — presentCambridge, Massachusetts, United States
- The Harry Glorikian ShowHost of The Harry Glorikian Showcurrent2018 — presentLexington, Massachusetts, United States
- Collective EquityAdvisorcurrent2025 — presentLondon Area, United Kingdom
- Northeastern UniversityMember of Northeastern University Bioengineering Industrial Advisory Board2022 — 2026Boston, Massachusetts, United States
- Beth Israel Deaconess Medical CenterMember of Industry Advisory Committee2020 — 2026Boston, Massachusetts, United States
- StageZero Life SciencesMember Board of Directors2008 — 2026Greater Toronto Area, Canada
- Consilience aiCo-Founder and CEO2021 — 2025United States
- BiocartisBoard Of Directors2018 — 2020Belgium
- Drawbridge HealthAdvisor and Co-Founder2015 — 2020
- Evidation HealthAdvisory Board2015 — 2018Menlo Park, CA
- CibusMember Board of Advisors2012 — 2017San Diego County, California, United States
- CepheidStrategic Advisory Board Member2014 — 2016Sunnyvale, CA
- GE Ventures, New Business CreationEntrepreneur in Residence2014 — 2016Boston/Menlo Park
- DraperMember, Biomedical Advisory Board2006 — 2015Cambridge, MA
- Precision For MedicineSenior Advisor2014Cambridge, MA
- Precision For MedicineManaging Director2012 — 2014Cambridge, MA
- Scientia AdvisorsManaging Partner2004 — 2014Cambridge, MA
- Applied BiosystemsSenior Manager, Business Development1997 — 2004Framingham, MA
- Signet LaboratoriesNational Sales Manager1994 — 1997Dedham, MA
- X-Cell LaboratoriesCo-Founder1993 — 1994San Francisco Bay Area
- BioGenex LaboratoriesSales & Marketing Manager1990 — 1993San Ramon, CA
Skills & more
+12 more
Product ManagementBusiness StrategyGenomicsR&DProduct DevelopmentMolecular BiologyHealthcareOncologyStrategic PlanningStrategy DevelopmentNegotiationMarket AnalysisLanguages Armenian · Italian
- THE TRAIN THE TRAINER IN PERSON WORKSHOP — Vjal Institute
From Harry's professional profile.
Deals · 1
GenenewsBoard seat
via Scientia Ventures · filed Jul 2017 · $245.6K raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
EmeraldIsablMarketMuseTransparency Life Sciences
Sources: SEC Form D filings · curated public sources.
Colleagues at Scientia Ventures
Frequently asked questions
- Who is Harry Glorikian?
- Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, with over three decades of experience building, investing in, and advising companies across healthcare, life sciences, and data-driven technology. He previously served as an Entrepreneur-in-Residence at GE Ventures' New Business Creation Group, where he co-founded Evidation Health and DrawBridge Health, and earlier co-founded and led Scientia Advisors, which Precision for Medicine acquired in 2012. He is the author of four books and hosts a podcast on AI and the data-driven transformation of healthcare, and holds an MBA from Boston University and a bachelor's degree from San Francisco State University.
- Where does Harry Glorikian work?
- Harry Glorikian is General Partner at Scientia Ventures.
- What does Harry Glorikian invest in?
- Harry Glorikian invests in AI & Machine Learning, Biotech, Digital Health, Healthtech.
- What boards does Harry Glorikian sit on?
- Harry Glorikian holds tracked board seats at Genenews.
- What companies has Harry Glorikian invested in?
- Investments tracked here include Emerald, Isabl, MarketMuse, Transparency Life Sciences.
- Where did Harry Glorikian go to school?
- Harry Glorikian studied at Boston University (MBA); San Francisco State University (BA, Biology).
Same school
Also attended Boston University556
+ 550 more
Also attended San Francisco State University147
+ 141 more
Shared employers
Also worked at MIT Media Lab172
+ 166 more
